CRP and COVID-19: Systemic inflammation evoked by SARS-CoV-2 is a hallmark of COVID-19, and one of the most widely used biomarkers for inflammation is an acute-phase protein CRP, which is biosynthesized in the liver in response to elevated interleukin-6 levels14,15.